Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670499 · ClinicalTrials.gov registry record · NA
Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR
A NA study of Total Knee Replacement, sponsored by Xeras Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT02670499 is a NA study of Total Knee Replacement that has completed, run by Xeras Medical Technologies. The registered enrollment target is 28 participants, below the 213-participant average among 9 other Total Knee Replacement trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02670499, a NA study of Total Knee Replacement, has completed, sponsored by Xeras Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
Post Market TKR study
Conditions Studied
Interventions
- DEVICE CPM
- DEVICE GAPFLEX
Study Locations (2)
Texas
- Nix Orthopaedic Center - San Antonio
- Orthopaedic Institute - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-11-18 |
| Est. Completion | 2017-06-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02670499
The ClinicalTrials.gov registry entry for NCT02670499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 9 other Total Knee Replacement trials with a reported enrollment target (87% lower). The listed sponsor is Xeras Medical Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Total Knee Replacement appearing as the primary indexed condition, and to 2 interventions - of which CPM is the first listed.
NCT02670499 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02670499 about?
NCT02670499 is a clinical study titled "Study Comparing GAP-Flex to CPM Therapy in Treatment of TKR". Post Market TKR study
What is the current status of trial NCT02670499?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-11-18. Estimated completion is 2017-06-23.
What conditions does trial NCT02670499 study?
This clinical trial studies the following conditions: Total Knee Replacement.
What interventions are being tested in trial NCT02670499?
The interventions under investigation include: CPM (DEVICE), GAPFLEX (DEVICE).
Who is sponsoring clinical trial NCT02670499?
This trial is sponsored by Xeras Medical Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02670499 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Replacement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Knee Arthroplasty Activity Trial
ACTIVE NOT RECRUITING · NA
-
X-3 Polyethylene Survival Outcomes Study
COMPLETED · NA
-
Mindfulness Meditation Intervention Study
COMPLETED · NA
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study
RECRUITING · Phase 2
-
An Open Label Data Collection Study of My Connect Post-Op, a Post-Operative Communication Tool
RECRUITING
-
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.